Cargando…
Responsiveness and minimal important differences for patient reported outcomes
Patient reported outcomes provide the patient's perspective on the effectiveness of treatment. The draft Food and Drug Administration guidance on patient reported outcomes for labeling and promotional claims raises a number of method and measurement issues that require further clarification, in...
Autores principales: | Revicki, Dennis A, Cella, David, Hays, Ron D, Sloan, Jeff A, Lenderking, William R, Aaronson, Neil K |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1586195/ https://www.ncbi.nlm.nih.gov/pubmed/17005038 http://dx.doi.org/10.1186/1477-7525-4-70 |
Ejemplares similares
-
Between-group minimally important change versus individual treatment responders
por: Hays, Ron D., et al.
Publicado: (2021) -
The case for an international patient-reported outcomes measurement information system (PROMIS(®)) initiative
por: Alonso, Jordi, et al.
Publicado: (2013) -
Development of physical and mental health summary scores from the patient-reported outcomes measurement information system (PROMIS) global items
por: Hays, Ron D., et al.
Publicado: (2009) -
Minimum important difference is minimally important in sample size calculations
por: Wong, Hubert
Publicado: (2023) -
Predicting EuroQol (EQ-5D) scores from the patient-reported outcomes measurement information system (PROMIS) global items and domain item banks in a United States sample
por: Revicki, Dennis A., et al.
Publicado: (2009)